Understand · Treat · Recover

Prognosis, Follow-up and Survivorship

Your outlook depends on your particular cancer and response to treatment. Follow-up looks after both cancer control and the effects of treatment on everyday life.

Patient education only. This guide does not diagnose cancer or prescribe treatment. Your team must adapt decisions to your cancer, health, preferences and local resources.

All 25 chapters

Chapter 24 of 25

Understanding prognosis without losing the individual

Prognosis means the likely course of an illness. For head and neck cancer, the exact site, cell type and stage matter. HPV association changes the outlook for oropharyngeal cancer, but does not make cancer harmless. General fitness, other illnesses, nutrition, treatment completion and response also influence outcomes. A single five-year survival figure for every head and neck cancer would be misleading.

After surgery, clear margins—no cancer at the edge of the removed tissue—and whether cancer has grown outside a lymph node help determine recurrence risk and additional treatment. These findings must be interpreted with the complete report. In advanced disease, the extent of spread, prior treatment and available options matter. Ask your oncologist to explain what is known, what remains uncertain and which factors can still be improved.

How to read survival numbers

Survival statistics describe groups treated in particular places and periods. Overall survival counts survival regardless of the cause of death; disease-specific and relative survival answer different questions. A median is a midpoint, not a deadline. Results from a trial may not apply directly to a person with a different cancer site, previous treatment or general health.

You can choose how much detail you want. Useful questions include: 'Is cure a realistic aim?', 'What range of outcomes do people in my situation experience?' and 'How might the outlook change after the next assessment?' Some people prefer numerical ranges, while others prefer a broad explanation. Hope can include cure, longer control, better function and meaningful time with family; honest discussion helps treatment match those priorities.

Response, remission and recurrence

A complete response means the available tests no longer show cancer; it does not prove that every microscopic cell is gone. A partial response means the cancer has shrunk according to assessment criteria. Stable disease means it has not changed enough to qualify as response or progression. Remission describes a reduction or disappearance of evidence of cancer and may be partial or complete.

Persistent disease remains after treatment. Recurrence is cancer returning after a period when it was no longer detectable, at the original site, nearby nodes or elsewhere. These terms should not be interpreted from a scan sentence alone. Inflammation after treatment can complicate imaging. The team may recommend observation, repeat imaging or biopsy to clarify a finding. Do not stop a planned treatment course solely because a lump has disappeared.

What follow-up appointments involve

Visits are generally closer together early after treatment and become less frequent over time, but the schedule depends on site, stage, treatment, symptoms and current local guidance. Examinations may include the mouth, neck and flexible endoscopy. Your team will arrange a suitable baseline response assessment and further imaging according to findings and risk; routine PET-CT at every visit is not appropriate for everyone.

Do not wait for your next appointment if you develop a persistent new lump, bleeding, worsening swallowing, new voice change, unexplained weight loss or persistent pain. Bring a symptom list and tell the team about functional or emotional difficulties as well as fears about recurrence. A written survivorship plan should identify who arranges scans, thyroid tests, dental care and rehabilitation, and whom to contact between visits.

Long-term health and second cancers

Neck radiation can reduce thyroid function, sometimes years later. The team may check thyroid blood tests periodically, commonly every six to twelve months when relevant, and investigate fatigue, feeling cold or unexplained weight change. Dental checks, preventive fluoride when prescribed, nutrition reviews and swallowing assessments remain important after the visible treatment effects settle.

Tell every dentist about prior head and neck radiation before an extraction or other invasive treatment. Dry mouth and reduced jaw opening may persist, and late swallowing problems need assessment even years after treatment. Hearing, shoulder function, neck stiffness, lymphedema and emotional wellbeing should be part of survivorship care rather than accepted as unavoidable problems.

Stopping tobacco reduces future health risks and is valuable even after diagnosis. Ask about counselling and appropriate cessation medicines. Avoiding alcohol is the safest cancer-risk choice; people who are alcohol-dependent need medical help to stop safely. Survivors can develop a separate new primary cancer, so discuss risk-appropriate screening rather than assuming every future symptom is recurrence.

Returning to work and daily life

Return gradually to activities that matter to you. Consider shorter working hours, rest breaks, meal arrangements and communication aids. A job involving heavy physical effort, dust exposure, voice use or driving may need a tailored assessment. Check driving safety if pain medicines, fatigue, neck movement or other symptoms could interfere.

Recurrence anxiety often increases before scans and appointments. It can help to agree when results will be discussed, write down questions and limit repeated searches for statistics that do not fit your situation. Seek counselling if worry dominates daily life. Recovery does not follow a fixed timetable; progress may mean better comfort, safer eating or increased independence even when some lasting changes remain.

References and evidence review

Evidence/editorial check: 25 October 2026. AI-assisted preparation is distinct from individual physician review. See the linked review policy for source-access limits and review status. Regulatory indications, reimbursement and availability vary by country. Trial results alone do not establish approval everywhere; your treating team should confirm the applicable current guidance.